Inflammatory myopathies

Acta Clinica Belgica

Volumn 59, Issue 5, 2004, Pages 290-299

  Cherin, P ^a  

^a PITIÉ SALPÊTRIÈRE HOSPITAL   (France)

Author keywords

[No Author keywords available]

Indexed keywords

ALANINE AMINOTRANSFERASE; ANTINUCLEAR ANTIBODY; ASPARTATE AMINOTRANSFERASE; AUTOANTIBODY; AZATHIOPRINE; CORTICOSTEROID; CREATINE KINASE; CYCLOPHOSPHAMIDE; CYCLOSPORIN A; ETANERCEPT; FLUDARABINE; FRUCTOSE BISPHOSPHATE ALDOLASE; HYDROXYCHLOROQUINE; IMMUNOGLOBULIN; INFLIXIMAB; INTEGRIN RECEPTOR; LACTATE DEHYDROGENASE; MATRIX METALLOPROTEINASE INHIBITOR; METHOTREXATE; METHYLPREDNISOLONE SODIUM SUCCINATE; MUSCLE ENZYME; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; PREDNISONE; TACROLIMUS; TUMOR NECROSIS FACTOR ALPHA ANTIBODY;

BLADDER DISEASE; CLINICAL FEATURE; CLINICAL TRIAL; DERMATOMYOSITIS; DIFFERENTIAL DIAGNOSIS; ELECTROMYOGRAPHY; HISTOPATHOLOGY; HUMAN; HUMORAL IMMUNITY; INCLUSION BODY MYOSITIS; LABORATORY TEST; MYOSITIS; NUCLEAR MAGNETIC RESONANCE IMAGING; PATHOGENESIS; PLASMAPHERESIS; POLYMYOSITIS; PROGNOSIS; REVIEW; T LYMPHOCYTE;

EID: 11144308768     PISSN: 00015512     EISSN: None     Source Type: Journal    
DOI: 10.1179/acb.2004.043     Document Type: Review

References (32)

1. Dalakas MC, Hohlfeld R. Polymyositis and dermatomyositis. Lancet 2003; 362:971-82.
2. Cherin P.: Recognition and management of myositis. Drugs, 1997, 54 : 39-49.
3. Cherin P., Herson S.,Crevon M.C., Hauw J.J., Cervera P., Galanaud P., Emilie D. : Mechanisms of lysis by activated cytotoxic cells expressing perforin and granzyme-B genes and the protein TIA-1 in muscle biopsies of myositis. J. Rheumatol., 1996, 23 : 1135-42.
4. Cherin P, Herson S, Godeau P : Physiopathogénie des dermatomyosites et des polymyosites : mise au point. Ann. Méd. Interne, 1990, 141: 156-9.
5. Cherin P. : Treatment of Inclusions Body Myositis. Cur. Op. Rheumatol., 1999, Nov; 11 (6) : 456-61
6. Amato AA, Gronseth GS, Jackson CE, et al. Inclusion body myositis: clinical and pathological boundaries. Ann Neurol 1996; 40:581-6.
7. Miller FW: Seasonal, geographical, clinical and immunogenetic associations of the myositis-specific autoantibodies. In Nervous system muscles and systemic diseases, Exp. Scient. Fran. 1993; 123-7.
8. Bernstein R.M., Morgan S.H., Chapman J., et col. : Anti JO-1 antibody : a marker for myositis with interstitial lung disease. Br. Med. J. 1984; 289: 151-2.
9. Dion E, Cherin P , Payan C, Fournet Jc, Papo T, Maisonobe T, Auberton E, Chosidow O, Godeau P, Piette Jc, Herson S, Grenier P : Magnetic resonance imaging criteria for distinguishing between inclusion body myositis and polymyositis. J Rheumatol 2002 ; 29 : 1897-906.
10. Hohlfeld R, Engel AG. The immunobiology of muscle. Immunol Today 1994; 15:269-74.
11. Whitaker J.N, Engel W.K : Vascular depositis of immunoglobulin and complement in idiopathic inflammatory myopathy. N. Engl. J. Med. 1972; 286: 333-8.
12. Arahata K, Engel AG : Monoclonal antibody analysis of mononuclear cells in myopathies. Ann. Neurol. 1984; 16: 193-208.
13. Kissel Jt, Mendell Jr, Rammohan KW : Microvascular deposition of complement attack complex in dermatomyositis. N. Engl. J. Med. 1986; 314: 329-34.
14. Mantegazza R, Andreetta F, Bernasconi P, et al. Analysis of T cell receptor repertoire of muscle infiltrating T lymphocytes in polymyositis: restricted V a/b rearrangements may indicate antigen-driven selection. J Clin Invest 1993; 91:2880-6.
15. Benveniste O, Cherin P, Maisonobe T, et al. Severe perturbations of the blood T cell repertoire in polymyositis, but not dermatomyositis patients. J Immunol 2001; 167:3521-9.
16. Choi Y, Dalakas MC. Expression of matrix metalloproteinases in the muscle of patients with inflammatory myopathies. Neurology 2000; 54:65-71.
17. Hofbauer M, Wiesner S, Babbe H, et al. Clonal tracking of autoaggressive T cells in polymyositis by combining laser microdissection, single-cell PCR and CDR3 spectratype analysis. Proc Natl Acad Sci U S A 2003; 100:4090-5.
18. Muntzing K, Lindberg C, Moslemi AR, Oldorfs A. Inclusion body myositis: clonal expansions of muscle-infiltrating T cells persist over time. Scand J Immunol 2003; 58:195-200.
19. Bohan A, Peter JB, Polymyositis and dermatomyositis (first of two parts). N Engl J Med. 1975, Feb 13; 292(7): 344-7.
20. Bohan A, Peter JB, Polymyositis and dermatomyositis (second of two parts). N Engl J Med. 1975, Feb 20; 292(8): 403-7.
21. Bunch T.W., Worthington J.W., Combs J.J., Ilstrup D.M., Engel A.G. : Azathioprine with prednisone for polymyositis. A controlled clinical trial. Ann. Intern. Med. 1980, 92, 365-9.
22. Miller F., Leitman S.F., Cronin M.E., et al. : Controlled trial of plasma exchange and leukapheresis in polymyositis and dermatomyositis. N. Engl. J. Med. 1992, 326: 1380-2.
23. Dalakas M.C., Illa I., Dambrosia J.M., Soueidan S.A., Stein D.P., Otero C., et col. : A controlled trial of high dose intravenous immune globulin, infusions as treatment for dermatomyositis. N. Engl. J. Med. 1993, 329 : 1993-2000.
24. Malaviya AN, Many A, Schwartz RS Treatment of dermatomyositis with methotrexate. Lancet, 1968 Aug 31; 2 (7566): 485-8.
25. Cherin P., Herson S., Wechsler B., et al. : Intravenous immunoglobulin and polymyositis. Lancet, 1990, 2, 116.
26. Cherin P., Herson S., Wechsler B., Piette J.C., Bletry O., Coutellier A., Ziza J.M., Godeau P. : Efficacy of intravenous gammaglobulin therapy in chronic refractory polymyositis and dermatomyositis: An open study with 20 adult patients. Am. J. Med., 1991, 91, 162-8.
27. Cberin P , Pelletier S, Teixeira A, Laforet P, Genereau T, Simon A, Maisonobe T, Eymard B, Herson S : Results and long-term follow-up of intravenous immunoglobulin infusions in chronic refractory polymyositis : an open study with 35 adult patients. Arthritis Rheum. 2002; 46 : 467-74.
28. Cherin P., Piette J.C., Wechsler B., Bletry O., Ziza J.M., Laraki R. Godeau P, Herson S. : Intravenous gammaglobulin as first line therapy in polymyositis and dermatomyositis: a report of 11 cases. J. Rheumatol. 1994, 21, 1092-7.
29. Bendtzen K, Tvede N, Andersen V, Bendixen G, Cyclosporin for polymyositis. Lancet. 1984, Apr 7; 1 (8380): 792-3.
30. Grau JM, Herrero C, Casademont J, Fernandez-Sola J, Urbano-Marquez A: Cyclosporine A as first choice therapy in dermatomyositis. J. Rheumatol. 1994, 21: 381-2.
31. Cherin P., Pourrat J., Bussel A., Auperin I., HERSON S. : Plasma exchange in polymyositis and dermatomyositis: Analysis of 57 cases. Clin. Exp. Rheum., 1995, 13 : 270-1.
32. Escalante A, Miller L, Beardmore TD: Resistive exercice in the rehabilitation of polymyositis/dermatomyositis. J. Rheumatol. 1993, 20: 1340-4.